{"schema_version":"secwatch.filing_event.v1","accession":"0001641172-25-020574","form_type":"8-K","ticker":"PPCB","cik":"0001517681","company_name":"Propanc Biopharma, Inc.","filed_at":"2025-07-22T23:59:59+00:00","discovered_at":"2026-05-14T18:02:44.194946+00:00","generated_at":"2026-05-18T04:16:01.838791+00:00","sec_items":["1.01","2.03","3.02","9.01"],"event_type":"debt","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Propanc Biopharma issues $82,500 promissory note to accredited investor","bullets":["Principal amount $82,500; purchase price $75,000; 10% annual interest.","Maturity date September 15, 2025; proceeds used for general working capital.","Repayment: 100% of principal if repaid by Aug 18, 2025; 120% if after Aug 18 up to Sept 18, 2025.","Note issued under private placement exemption Rule 506/Reg D; no equity securities sold."],"urls":{"canonical":"https://secwatch.observer/filing/0001641172-25-020574","json":"https://secwatch.observer/filing/0001641172-25-020574.json","markdown":"https://secwatch.observer/filing/0001641172-25-020574.md","text":"https://secwatch.observer/filing/0001641172-25-020574.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1517681/000164117225020574/0001641172-25-020574-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1517681/000164117225020574/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-18T04:16:01.838791+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"6ffd87e2be90b47f0d855f80fc20d5aa956d6625","claim":"Propanc Biopharma, Inc. incurred convertible notes of $82,500 with an accredited investor at 10% per annum maturing September 15, 2025.","evidence_excerpt":"Effective July 18, 2025, Propanc Biopharma, Inc. (the “Company”) issued a Promissory Note to an accredited investor (the “Investor”) in the aggregate principal amount of 82,500 (the “Note”), for a purchase price of $75,000.","evidence_source":"SEC 8-K Item 2.03/2.04","evidence_url":"https://www.sec.gov/Archives/edgar/data/1517681/000164117225020574/0001641172-25-020574-index.htm","confidence":0.95,"family_label":"Debt Financings","details":[{"label":"Instrument","value":"convertible notes"},{"label":"Principal","value":"$82,500"},{"label":"Counterparty","value":"an accredited investor"},{"label":"Rate","value":"10% per annum"},{"label":"Maturity","value":"September 15, 2025"},{"label":"Event","value":"incurrence"}],"fact_type":"debt_financing"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}